Customer Input Drives Expansion of OGT#s Cytocell Aquarius(R) Haematology FISH Probe Range

Food and Healthcare Press Releases Tuesday October 11, 2016 10:00
OXFORD, England--11 Oct--PRNewswire/InfoQuest

Oxford Gene Technology (OGT), The Molecular Genetics Company, has today announced a significant expansion of its existing catalogue of   Cytocell Aquarius (R) Haematology probes for fluorescence in situ hybridisation (FISH) - underlining the company's position as the one-stop-shop for high-quality FISH probes. These additions have been introduced due to an ongoing commitment to use customer input as a major driver for the rapid development of the latest research-relevant probes. The 14 newly launched probes are:

CBFB Proximal Probe Red           CSF1R/RPS14 (5q32-q33) Probe Red
CBFB Distal Probe Green           EGR1/CDC25C (5q31) Probe Green
MECOM Probe Red           TERT (5p15.33) Probe Aqua
RUNX1 Probe Green           CUX1 (7q22) Probe Green
NUP98 Proximal Probe Red           EZH2 (7q36) Probe Red
NUP98 Distal Probe Green           Chromosome 7 Alpha Satellite Probe Aqua
TET2 Probe Red
USP46 (4q12) Probe Green
(Logo: http://photos.prnewswire.com/prnh/20160909/406091LOGO )
The new cost-effective and quality-assured probes are optimised for use on common sample types and are sold as pre-mixed, easy-to-use formulations to minimise experimental errors.

As the longest-standing FISH probe manufacturer in the world, 2016 marks 25 years of Cytocell expertise and customer service in the development and production of FISH products. "Our myProbes custom probe service gives us the opportunity to get continuous customer input," explains Faidra Partheniou, Haematology Product Manager at OGT. "It truly helps us to respond quickly to changes in customer demand and it helps researchers by providing a first port of call for rapid development of new probes. These latest additions to our Cytocell Aquarius portfolio are testament to this."

OGT also offers the opportunity to evaluate the accurate, user-friendly FISH probes in customer's own labs free of charge by simply requesting up to four free probes from their extensive range.
To find out more about the comprehensive range of Cytocell FISH probes and to request a free sample, please visit http://www.cytocell.com .

The new additions to the Cytocell Aquarius(R) Haematology probe range are currently only available within North America as analyte specific reagents (ASRs), analytical and performance characteristics are not established. CE-marked IVD versions for sale in Europe are anticipated.

US: myProbes(R) - Analyte Specific Reagent. Analytical performance characteristics are not established. ROW: myProbes(R) - For Research Use Only; Not for Use in Diagnostic Procedures. Cytocell: Some products may not be available in the US.

Source: Oxford Gene Technology (OGT)

Latest Press Release

Michel Orsinger Assumes Role as Chairman of Limacorporate#s Advisory Board

LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will assume the role of Chairman of the Board. Michel joined the Advisory Board mid-2017 following a long and successful global career in...

Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the...

APEC#s Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025

- Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). - Aims to define, diagnose and...

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Ascensia Diabetes Care Highlights the Support That Families Provide for People With Diabetes To Mark World Diabetes Day 2018

Today, Ascensia Diabetes Care, a global leading diabetes care company, launched their campaign for World Diabetes Day 2018 to celebrate the important role of families for people with diabetes. They are publishing 38 online artworks that tell the stories...

Related Topics